Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Risk of mortality associated with concomitant antidepressant and benzodiazepine therapy among patients with depression: a population-based cohort study

Fig. 2

Risk of all-cause mortality, suicide attempt/self-harm, and all-cause hospitalization for antidepressant monotherapy and antidepressant+benzodiazepine concomitant therapy in the propensity score-matched cohort. Note: AD, antidepressant; BZD, benzodiazepine; CI, confidence interval; IR, incidence rate; RD, risk difference. *Incidence rate = (number of events/total person-years) × 1000. †Adjusted for age, sex, CCI, comorbidities, and concomitant medications

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us